Sep 13, 2022 / 11:20AM GMT
Neha Begwani -
Thank you, everybody, for joining us for the second day of the Morgan Stanley Healthcare Conference. My name is Neha Begwani and I'm part of the Morgan Stanley Investment Banking team. I'm pleased to be joined by the Senseonics Group here. We have Tim Goodnow, CEO; and Rick Sullivan, CFO. Before we jump into today's discussion, I want to do the quick disclosure. So please see Morgan Stanley Research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to Morgan Stanley sales representatives.
And with that, maybe to kick us off, if you can give us a brief overview of the company, the Eversense technology. It's a very exciting, important platform So Just to kind of level set today's discussion.
Timothy T. Goodnow - Senseonics Holdings, Inc. - President, CEO & Director
Sure. Well, we appreciate the opportunity to speak today and thank to folks at Morgan Stanley for having us. So Senseonics is a medical technology company, obviously, in the continuous glucose monitoring space. We've been at this
Senseonics Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers